BiotechTube

injectable poly-L-lactic acid

ApprovedCompleted
0 watching 0 views this week🔥 Hot
84
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Problem of Aging

Conditions

Problem of Aging

Trial Timeline

Jan 1, 2011 → Jun 1, 2013

NCT ID
NCT01307865

About injectable poly-L-lactic acid

injectable poly-L-lactic acid is a approved stage product being developed by Sanofi for Problem of Aging. The current trial status is completed. This product is registered under clinical trial identifier NCT01307865. Target conditions include Problem of Aging.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01307865ApprovedCompleted

Competing Products

11 competing products in Problem of Aging

See all competitors
ProductCompanyStageHype Score
3% Diquafosol tetrasodiumSanten PharmaceuticalPre-clinical
23
MarvelonMerckApproved
85
somatropin + somatropin + somatropinNovo NordiskApproved
84
somatropinNovo NordiskPhase 3
76
somatropinNovo NordiskPhase 3
76
somatropinNovo NordiskPre-clinical
22
somatropin + somatropinNovo NordiskPhase 3
76
somatropinNovo NordiskApproved
84
somatropinNovo NordiskPhase 3
76
somatropin + somatropinNovo NordiskApproved
84
somatropin + No treatment given + No treatment givenNovo NordiskPre-clinical
22

Other Products from Sanofi

Adacel®Approved
84
LACTIC ACID(ND)Approved
84
DupilumabApproved
84
glatiramer acetateApproved
84
INSULIN GLULISINE + INSULIN GLARGINEApproved
84